For the Inventor, By the Inventor

Enter assignee name

Hamilton, Bermuda

Abbvie Biotechnology Ltd

USPTO Granted Patents = 93

CIPO Patents = 13

EPO Patents = 20

Trademarks = 26

Forward Citations = 1,969

Loading Chart...

Loading Chart...

104 inventors (with patents filed for the assignee):

Hans-Juergen Krause (26 out of 32 patents)

Lisa Baust (21 out of 22 patents)

Michael Dickes (21 out of 22 patents)

4. Joseph F Julian (16 out of 32 patents)

5. Rebecca S Hoffman (16 out of 16 patents)

6. Lori K Taylor (11 out of 11 patents)

7. Philip Yan (11 out of 11 patents)

8. Elliot Keith Chartash (11 out of 14 patents)

9. George Richard Granneman (11 out of 12 patents)

10. Min M Wan (10 out of 13 patents)

11. George Avgerinos (10 out of 14 patents)

12. Gregory Zarbis-Papastoitsis (10 out of 13 patents)

13. Steven Alan Fischkoff (10 out of 14 patents)

14. Chuan Li (8 out of 15 patents)

15. Mark Weinberg (8 out of 21 patents)

Core Competencies:

Automatic Injection Devices

Protein Formulations

Purified Antibody Composition

Human Antibodies

TNF-alpha Associated Disorders

Wearable Injection Device

Anti-TNF Antibody Formulations

Multiple-Variable Dose Regimen

Juvenile Idiopathic Arthritis

Psoriatic Arthritis Treatments

Skin Disorder Treatments

Biomarkers for Diagnosing

93 patents: Sort by Forward Citations

1. 11565048 - Automatic injection devices having overmolded gripping surfaces (2023-01-31),

2. 11191834 - Protein formulations and methods of making same (2021-12-07),

3. 11167030 - Protein formulations and methods of making same (2021-11-09),

4. 11083792 - Purified antibody composition (2021-08-10),

5. 10022503 - Removal of needle shield from syringes and automatic injection devices (2018-07-17),

6. 9950066 - Formulation of human antibodies for treating TNF-alpha associated disorders (2018-04-24),

7. 9913902 - Purified antibody composition (2018-03-13),

8. 9878102 - Automatic injection devices having overmolded gripping surfaces (2018-01-30),

9. 9821117 - Wearable automatic injection device for controlled delivery of therapeutic agents (2017-11-21),

10. 9764090 - Relating to automatic injection devices (2017-09-19),

11. 9750808 - Formulation of human antibodies for treating TNF-alpha associated disorders (2017-09-05),

12. 9738714 - Formulation of human antibodies for treating TNF-alpha associated disorders (2017-08-22),

13. 9732152 - Formulation of human antibodies for treating TNF-alpha associated disorders (2017-08-15),

14. 9669093 - Methods for treating juvenile idiopathic arthritis (2017-06-06),

15. 9624295 - Uses and compositions for treatment of psoriatic arthritis (2017-04-18),

AbbVie Biotechnology Ltd is a leading biotechnology company that focuses on researching, developing, and delivering innovative therapies in the fields of immunology, oncology, neuroscience, and virology. With a mission to improve patients' lives, AbbVie Biotechnology is dedicated to discovering breakthrough treatments and providing advanced healthcare solutions worldwide.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 30 2025

93 Patents

#9 in Hamilton

#9 in Bermuda

#8,053 in the World

Hamilton, Bermuda

Abbvie Biotechnology Ltd

Forward Citations = 1,969

104 inventors:

Hans-Juergen Krause (26 out of 32 patents)

Lisa Baust (21 out of 22 patents)

Michael Dickes (21 out of 22 patents)

4. Joseph F Julian (16 out of 32 patents)

5. Rebecca S Hoffman (16 out of 16 patents)

Please report any incorrect information to support@idiyas.com

Loading…